Natasha Salant
MPhil
DPhil Student
Natasha joined the Health Economics Research Centre (HERC) as a researcher in September 2023, and began her DPhil in October 2024.
Her research focuses on diagnostic interventions for antimicrobial resistance (AMR), and modelling the epidemiological and economic impact in the UK and Malawi.
She is also conducting research to evaluate the economic and epidemiological consequences of vaccine implementation strategies for chikungunya.
Prior to joining HERC, Natasha worked as a health economist in the Centre for Guidelines at the National Institute for Health and Care Excellence (NICE) where she conducted evidence reviews and developed models to assess the cost-effectiveness of clinical guidelines.
Natasha has also worked at the Clinton Health Access Initiative in Rwanda and South Africa where she worked with governments on health financing and health system strengthening.
Natasha holds an MPhil in Population Health Sciences from the University of Cambridge.
Recent publications
Organizational readiness for implementing infection control in European hospitals: insights from Coincidence Analysis
Journal article
Caci L. et al, (2026), Implementation Science Communications, 7
Umbrella review of economic evaluations of interventions for the prevention and management of healthcare-associated infections in adult hospital patients
Journal article
Pollard J. et al, (2025), Journal of Hospital Infection, 158, 47 - 60
Health-economic burden of chikungunya infection and potential cost-effectiveness of preventive vaccination in 31 countries
Preprint
Zhou J. et al, (2025)
Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda
Journal article
Nemzoff C. et al, (2024), Cost Effectiveness and Resource Allocation, 22
Does workforce explain the relationship between funding and patient experience? A mediation analysis of primary care data in England
Journal article
Salant N. et al, (2024), BMJ Open, 14